Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent &ITClostridium difficile&IT Infection
- Resource Type
- Journal
- Source
CLINICAL INFECTIOUS DISEASES ; FEB 1 2018, 66 3, p355-p362, 8p.- Subject
- Language
- English
- ISSN
- 15376591